Evidence
- bailey-ayling_2018_cohort_the-pharmacokinetic-advantage-of-5-methyltetrahydrofolate-for-minimization-of-the-risk-for-birth-defects
- bailey-ayling_2018_cohort_the-pharmacokinetic-advantage-of-5-methyltetrahydrofolate-for-minimization-of-the-risk-for-birth-defects
- bailey-ayling_2018_cohort_the-pharmacokinetic-advantage-of-5-methyltetrahydrofolate-for-minimization-of-the-risk-for-birth-defects